Original article
FLI and FIB-4 in diagnosing metabolic dysfunction-associated steatotic liver disease in primary care: High prevalence and risk of significant disease
Mário Reis Álvares-da-Silvaa,b,c,d,e,
, Márcia da Silva Vargasa,f, Soheyla Mohd Souza Rabiea,f, Gabriella Jonkoa, Patricia Gabriela Riedela, Larisse Longoa,b, Marcelo Rodrigues Gonçalvesg,h,j, Vivian Cristine Luftg,h,i, Dvora Jovelevithsa,b,g
Corresponding author
a Graduate Program in Gastroenterology and Hepatology, School of Medicine, Universidade Federal do Rio Grande do Sul (UFRGS), Porto Alegre, 90035-007, Rio Grande do Sul, Brazil
b Experimental Laboratory in Hepatology and Gastroenterology, Hospital de Clinicas de Porto Alegre (HCPA), Porto Alegre, 90035-007, Rio Grande do Sul, Brazil
c Gastroenterology and Hepatology Unit, HCPA, Porto Alegre, 90035-007, Rio Grande do Sul, Brazil
d Department of Internal Medicine, UFRGS, Porto Alegre, 91501-970, Rio Grande do Sul, Brazil
e Conselho Nacional de Desenvolvimento Científico e Tecnológico, CNPq Researcher, Brasília 71.605-001, Distrito Federal, Brazil
f Nutrition Unit, HCPA, Porto Alegre, 90035-007, Rio Grande do Sul, Brazil
g Department of Social Medicine, UFRGS, Porto Alegre, 90035-003, Rio Grande do Sul, Brazil
h Department of Nutrition, School of Medicine, UFRGS, Porto Alegre, 90050-170, Rio Grande do Sul, Brazil
i Graduate Program in Epidemiology, School of Medicine, UFRGS, Porto Alegre, 90035-003, Rio Grande do Sul, Brazil
j Graduate Program in Food, Nutrition and Health, School of Medicine, UFRGS, Porto Alegre, 90035-007, Rio Grande do Sul, Brazil
Ver más
